HealthEquity Inc. (HQY)
MD vs. HQY: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or HealthEquity (HQY). But which of these two stocks presents investors with the better value opportunity right now?
MD or HQY: Which Is the Better Value Stock Right Now?
Investors interested in Medical Services stocks are likely familiar with Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors?
Why Is HealthEquity (HQY) Down 2.2% Since Last Earnings Report?
HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock?
HealthEquity Stock Plunges 13% YTD: Is It Time to Exit or Hold?
HQY stock is down more than 13% YTD amid cyber threats and rising costs, but strong HSA fundamentals remain. Is it time to hold or fold?
MD vs. HQY: Which Stock Is the Better Value Option?
Investors interested in Medical Services stocks are likely familiar with Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?
Why HealthEquity Stock Was Sliding This Week
Over the past few days HealthEquity (HQY -0.46%) shares have been rather sickly. The health savings account (HSA) specialist's stock was rocked by a disappointing earnings report, and as a result its price was down by nearly 15% week to date as of mid-afternoon Thursday, according to data compiled by S&P Global Market Intelligence.
HealthEquity Stock Tumbles Despite the Launch of Assist Benefits Suite
HQY launches Assist Suite to integrate personalized support, simplify benefits, and enhance engagement, aiming to reduce costs and improve outcomes.
HealthEquity's Long-Term Growth Intact Despite Short-Term Margin Pressures, Analyst Says
On Tuesday, HealthEquity, Inc. HQY reported fourth-quarter adjusted EPS of 69 cents, up from 63 cents a year ago, missing the consensus of 72 cents.
HQY Stock Falls as Q4 Earnings Miss Estimates, Revenues Up Y/Y
HealthEquity surpasses fourth-quarter revenue expectations on robust HSA growth. It also provided fiscal 2026 guidance.
HealthEquity: Selling Off On Uncertainties
HealthEquity, Inc. had a strong 2024, but recent earnings missed expectations, causing shares to drop; stock likely to settle around $70. Despite mixed Q4 results, revenue grew 18.8% YoY; however, higher issuance costs and an above market multiple make current valuation less attractive. Positive metrics include a 14% increase in total HSAs and a 27% rise in total HSA assets; company also buying back stock.
HealthEquity Dives On Fraud Costs; HQY Erases Rally On Trump HSA Expansion Hopes
HQY stock wiped out its Trump election rally as the health savings account leader's earnings missed on elevated fraud costs. The post HealthEquity Dives On Fraud Costs; HQY Erases Rally On Trump HSA Expansion Hopes appeared first on Investor's Business Daily.
HealthEquity, Inc. (HQY) Q4 2025 Earnings Call Transcript
HealthEquity, Inc. (NASDAQ:HQY ) Q4 2025 Earnings Conference Call March 18, 2025 4:30 PM ET Company Participants Richard Putnam - Investor Relations Scott Cutler - President & Chief Executive Officer James Lucania - Executive Vice President & Chief Financial Officer Steve Neeleman - Vice Chair & Founder Conference Call Participants Glen Santangelo - Jefferies Gregory Peters - Raymond James Stan Berenshteyn - Wells Fargo Securities Anne Samuel - JPMorgan David Roman - Goldman Sachs Scott Schoenhaus - KeyBanc Mark Marcon - Baird Allen Lutz - Bank of America David Larsen - BTIG Sam Hasanov - Mizuho Operator Good afternoon, and welcome to the HealthEquity Fourth Quarter 2025 Earnings Conference Call. Please note this event is being recorded.
